Concentra Group Holdings Parent, Inc. (CON)
- Previous Close
21.53 - Open
21.70 - Bid 21.79 x 900
- Ask 24.45 x 1000
- Day's Range
21.40 - 21.98 - 52 Week Range
18.89 - 24.81 - Volume
433,746 - Avg. Volume
783,773 - Market Cap (intraday)
2.792B - Beta (5Y Monthly) --
- PE Ratio (TTM)
14.92 - EPS (TTM)
1.46 - Earnings Date May 7, 2025
- Forward Dividend & Yield 0.25 (1.15%)
- Ex-Dividend Date Mar 18, 2025
- 1y Target Est
27.88
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services. It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. In addition, the company provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards. The company was founded in 1979 and is based in Addison, Texas. Concentra Group Holdings Parent, Inc. was formerly a subsidiary of Select Medical Corporation.
www.concentra.com8,758
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CON
View MorePerformance Overview: CON
Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CON
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CON
View MoreValuation Measures
Market Cap
2.79B
Enterprise Value
4.56B
Trailing P/E
14.92
Forward P/E
15.77
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.31
Price/Book (mrq)
10.13
Enterprise Value/Revenue
2.40
Enterprise Value/EBITDA
12.38
Financial Highlights
Profitability and Income Statement
Profit Margin
8.77%
Return on Assets (ttm)
7.91%
Return on Equity (ttm)
23.29%
Revenue (ttm)
1.9B
Net Income Avi to Common (ttm)
166.33M
Diluted EPS (ttm)
1.46
Balance Sheet and Cash Flow
Total Cash (mrq)
183.26M
Total Debt/Equity (mrq)
653.23%
Levered Free Cash Flow (ttm)
185.93M